Using hematogram model to predict future metabolic syndrome in elderly: a 4-year longitudinal study

References

• Avagaro P CG, Enzi G, Tiengo A. Associazione di iperlidemia, diabete mellito e obesitia di medio gado. Acta Diabetol Lat 1967;4:36–41
   Google Scholar
• Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annual Rev Med 1993;44:121–31
   PubMed Web of Science ®Google Scholar
• Pacifico L, Anania C, Martino F, et al. Management of metabolic syndrome in children and adolescents. NMCD 2011;21:455–66
   Google Scholar
• Zimmet P, Alberti G, Kaufman F, et al. The metabolic syndrome in children and adolescents. Lancet 2007;369:2059–61
   PubMed Web of Science ®Google Scholar
• Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 2007;115:2316–22
   PubMed Web of Science ®Google Scholar
• Nagasawa N, Tamakoshi K, Yatsuya H, et al. Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circulation J 2004;68:892–97
   PubMed Web of Science ®Google Scholar
• Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol 2005;96:53E–9E
   PubMed Web of Science ®Google Scholar
• Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414–19
   PubMed Web of Science ®Google Scholar
• Chang TY, Chen JD. Fatty liver and metabolic syndrome in nonabdominally obese Taiwanese adults. Asia-Pacific J Public Health 2012;24:472–9
   PubMedGoogle Scholar
• Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245–50
   PubMed Web of Science ®Google Scholar
• Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Internal Med 2004;140:167–74
   PubMed Web of Science ®Google Scholar
• Watanabe H, Tanabe N, Watanabe T, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008;117:1255–60
   PubMed Web of Science ®Google Scholar
• Oltmanns KM. Abdominal fat and sleep apnea: the chicken or the egg? Response to Pillar and Shehadeh. Diabetes Care 2008;31:e61; author reply e62
   Google Scholar
• Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005;28:1472–9
   PubMed Web of Science ®Google Scholar
• Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Texas Heart Institute J 2013;40:17–29
   PubMed Web of Science ®Google Scholar
• Chuo SK, Li JC, Tsai WC, et al. Correlations between white blood cell count and metabolic syndrome in middle-age Taiwanese. Endocrine Res 2005;31:39–50
   PubMed Web of Science ®Google Scholar
• Hsieh CH, Pei D, Kuo SW, et al. Correlation between white blood cell count and metabolic syndrome in adolescence. Pediatr Int 2007;49:827–32
   PubMed Web of Science ®Google Scholar
• Wu CZ, Lin JD, Li JC, et al. Association between white blood cell count and components of metabolic syndrome. Pediatr Int 2009;51:14–18
   PubMed Web of Science ®Google Scholar
• Sikora J, Broncel M, Markowicz M, et al. Short-term supplementation with Aronia melanocarpa extract improves platelet aggregation, clotting, and fibrinolysis in patients with metabolic syndrome. Eur J Nutr 2012;51:549–56
   PubMed Web of Science ®Google Scholar
• Chang YL, Pei C, Pei D, et al. Association between platelet count and components of metabolic syndrome in geriatric Taiwanese males. Int J Gerontol 2012;6:215–19
   Google Scholar
• Chen YL, Hseih CH, Wang K, et al. Association between platelet count and components of metabolic syndrome in geriatric Taiwanese women. Int J Gerontol 2012;6:201–5
   Google Scholar
• Liu H, Hsu CH, Lin JD, et al. Predicting metabolic syndrome by using hematogram models in elderly women. Platelets 2014;25:97–101
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5
   PubMed Web of Science ®Google Scholar
• Department of Health EY, R.O.C. (Taiwan). Available from: http://www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no = 25&now_fod_list_no = 5912&level_no = 2&doc_no = 22602. [last accessed 10 Feb 2013]
   Google Scholar
• Ishizaka N, Ishizaka Y, Toda E, et al. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Intern Med 2007;46:1167–70
   PubMedGoogle Scholar
• Lohsoonthorn V, Jiamjarasrungsi W, Williams MA. Association of hematological parameters with clustered components of metabolic syndrome among professional and office workers in Bangkok, Thailand. Diabetes Metab Syndrome 2007;1:143–9
   PubMedGoogle Scholar
• Kotani K, Sakane N, Saiga K, et al. Clustered components of the metabolic syndrome and platelet counts in Japanese females. Clin Chem Lab Med 2007;45:376–9
   PubMed Web of Science ®Google Scholar
• Lao XQ, Neil Thomas G, Jiang C, et al. White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis 2008;201:418–24
   PubMed Web of Science ®Google Scholar
• Kim DJ, Noh JH, Lee BW, et al. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci 2008;23:193–8
   PubMed Web of Science ®Google Scholar
• Odagiri K, Uehara A, Mizuta I, et al. Longitudinal study on white blood cell count and the incidence of metabolic syndrome. Intern Med 2011;50:2491–8
   PubMedGoogle Scholar
• Jung CH, Lee WY, Kim BY, et al. The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults. Yonsei Med J 2013;54:615–20
   PubMedGoogle Scholar
• Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992;72:449–89
   PubMed Web of Science ®Google Scholar
• Pasarica M, Sereda OR, Redman LM, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009;58:718–25
   PubMed Web of Science ®Google Scholar
• Vij U, Murugesan K, Laumas KR, Farooq A. Progestin and antiprogestin interactions with progesterone receptors in human myomas. Int J Gynaecol Obstetr 1990;31:347–53
   PubMed Web of Science ®Google Scholar
• Regazzetti C, Peraldi P, Gremeaux T, et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2009;58:95–103
   PubMed Web of Science ®Google Scholar
• Hamalainen P, Saltevo J, Kautiainen H, et al. Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study. Cardiovascular Diabetol 2012;11:116
   PubMedGoogle Scholar
• Dovizio M, Alberti S, Guillem–Llobat P, Patrignani P. Role of platelets in inflammation and cancer: novel therapeutic strategies. Basic Clin Pharmacol Toxicol 2014;114:118–27
   Google Scholar
• Drouet L, Bal dit Sollier C, Henry P. The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients. Drugs 2010;70:9–14
   PubMedGoogle Scholar